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Aim To assess the efficacy of the procedural consolidation 
concept (PCC) at reducing the number of sessions of gen-
eral anesthesia necessary for treating children with epider-
molysis bullosa (EB).
Methods We examined the records of children treated at 
Children’s Hospital of Zagreb between April 1999 and De-
cember 2007. Children treated before the introduction of 
PCC in January 2005 (n = 39) and after (n = 48) were ana-
lyzed in order to determine the effect of PCC on the occur-
rence of complications, days of hospitalization, and num-
ber of hospitalizations.
Results During the study period, 53 patients underwent 
220 sessions of general anesthesia for a total of 743 sur-
gical interventions per session. Before the introduction of 
PCC (n = 39 patients, 83 sessions), the median number of 
interventions per session was 2 (range 1-5), and after the 
introduction of PCC (n = 48 patients, 137 sessions) it was 
4 (range 3-7, P < 0.001). After the introduction of PCC, the 
median number of complications per anesthesia session 
increased from 2 (range 0-10) to 3 (range 0-10) (P = 0.027), 
but the median number of complications per surgical pro-
cedure decreased from 1 (range 0-10) to 0.6 (range 0-2.5) 
(P < 0.001). PCC lengthened each anesthesia session from a 
median of 65 minutes (range 35-655) to 95 minutes (range 
50-405), (P < 0.001). Total length of hospitalization was simi-
lar before (median 1, range 1-4) and after (median 1, range 
1-3) introduction of PCC (P = 0.169). The number of hospi-
talization days per procedure was 3 times lower after the 
introduction of PCC (median 0.3, range 0.2-3) than before 
(median 1, range 0.75-1.7) (P < 0.001).
Conclusion PCC should be considered an option in the 
surgical treatment of children with EB.
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Epidermolysis bullosa (EB) refers to a group of rare genet-
ic disorders characterized by cutaneous and extracutane-
ous fragility, blistering, and subsequent scaring even after a 
mild mechanical stress (1). The hallmark feature of inherited 
EB is mechanical fragility (2). The illness is chronic, degener-
ative, difficult to treat, and lethal. Although the most com-
mon symptom of EB is bullae of skin epithelium, blisters 
may arise on virtually any mucosal surface (3). Bullae usually 
heal, leaving atrophic scars. Digital fusion following scar for-
mation is common, rendering the hands useless (3).
Traditionally, EB is divided into three major types based 
on phenotype, mode of inheritance, and genotype (4): EB 
simplex, junctional EB, and dystrophic EB. More recently, 
a fourth form, hemidesmosomal EB, was introduced to 
describe EB in which blisters emerge in the dermal-epi-
dermal circuit. Dystrophic EB is probably the most com-
mon form of surgically treated EB (5). Each major EB type 
has subtypes (4,6,7); two major subtypes of dystrophic EB 
are dominant dystrophic EB and recessive dystrophic EB. 
The overall prevalence for inherited EB in the American 
population is 8.22 per million (8). Prevalence of EB sim-
plex, junctional EB, dominant dystrophic EB, and reces-
sive dystrophic EB in the United States of America (USA) 
is 10.75, 2.04, 2.86, and 2.04 per million, respectively (8). 
Determining accurate prevalence and incidence data on 
inherited EB in the USA became possible only after the 
national EB registry was established in 1986 (9-11). A Cro-
atian national EB registry does not yet exist. According to 
a study in 1990 on a limited number of EB patients, the 
prevalence of the Hallopeau-Siemens subtype of reces-
sive dystrophic EB in Croatia was estimated at 9.6 people 
per million (12).
EB has become recognized as a multisystem disorder that 
poses a number of pre-, peri-, and postoperative challeng-
es (13). Scars, strictures, and stenoses are some of the prob-
lems that require surgical treatment (14). In addition, EB af-
fects the oral-gastrointestinal system, creating the need for 
operative treatment and significantly affecting periopera-
tive care (13).
Patients with EB are a high-risk group for anesthesiology 
because of malnutrition, anemia, hypoproteinemia, dilated 
cardiomyopathy, and limited mouth opening (15,16).
A multidisciplinary team approach to EB treatment is rec-
ommended. Preoperative preparation must be individu-
alized, with special attention given to the potential anes-
thetic problems. When procedures under anesthesia are 
planned, it is best to coordinate as many surgical proce-
dures as possible to avoid repeated anesthesia (17).
Surgical care for EB patients at the Children’s Hospital of 
Zagreb was for many years quite basic and was not codi-
fied into a uniform and standard procedure. In January 
2005, the hospital adopted a team approach to treating 
EB, which led to implementation of a procedural consoli-
dation concept (PCC).The standard approach of repeated 
sessions of anesthesia with no more than two surgical pro-
cedures performed each time (18-20) was replaced with 
PCC,  which  implied  multiple  surgical  approaches  and 
procedures during the same session of anesthesia. PCC 
is based on multidisciplinary team-based treatment plan-
ning aimed at reducing the number of times that patients 
with EB are subjected to general anesthesia. In this study, 
we analyzed whether PCC was successful at reducing the 
number of anesthesia sessions without increasing compli-
cations or length of hospitalization.
MethoDs
This is a retrospective study of medical records of all pa-
tients with EB who were surgically treated under general 
anesthesia in Children’s Hospital of Zagreb between April 
1999 and December 2007. The study was approved by the 
Institutional Review Board of Children’s Hospital of Zagreb. 
Written  informed  consent  was  obtained  from  patients, 
their parents, or their legal guardians prior to each anes-
thesia session.
All patients scheduled for surgery were reviewed by an 
EB team composed of a pediatrician, dermatologist, an-
esthesiologist, and two surgeons. Based on clinical exami-
nation by the multidisciplinary team and laboratory find-
ings, individual plans for surgical treatment were created 
for patients with EB. Patients were hospitalized on the day 
of surgery.
 A total of 220 anesthesia sessions were divided into two 
groups, those performed before (n = 83 sessions, 39 pa-
tients) and after (n = 137 sessions, 48 patients) the intro-
duction of PCC. The groups of patients treated before and 
after the introduction of PCC were compared in terms of 
observed  complications  per  general  anesthesia  session, 
per 10 minutes of anesthesia, total length of hospital stay, 
and number of hospitalizations. All perioperative compli-
cations were defined as short-term complications the 
occurrence of which did not affect duration of hospital 
stay. Follow-up period was during the hospital stay.CLINICAL SCIENCES 522 Croat Med J. 2011; 52: 520-6
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Premedication and anesthesia
Oral premedication was used in 41 (19%) of 220 sessions of 
general anesthesia. Midasolam was administered in syrup 
form. Intravenous (IV) access before induction in anesthesia 
was achieved in only 36 (16%) of 220 sessions, 21 of which 
were in children who had been premedicated. In all cases, 
induction in anesthesia was by inhalation. Until 2004, the 
inhalational anesthetic was Halothane (Halotan); from 2004 
onwards, it was Sevofluran (Sevoran). Of the total of 220 ses-
sions of anesthesia, 127 (58%) were carried out entirely with 
a “face” mask, while in the remaining 93 (42%) there were in-
dications for endotracheal tube insertion. Most intubations 
(62 of 93, 67%) were performed after introduction of PCC. A 
fiber-optic bronchoscope (Olympus BF-3C-20; Olympus Eu-
ropa GmbH, Hamburg, Germany) was used for intubation 
of infants and small children. For children over 10 years, an 
Olympus BF-P-20-D was used. The patients did not consent 
to the use of regional anesthesia.
The neuromuscular relaxant rocuronium and the opioid 
analgesic fentanyl were used to ensure good intubation 
and  calmness  during  the  surgery.  Pulse  oximeter  oxy-
gen  saturation,  electrocardiography,  non-invasive  blood 
pressure, blood loss, and body temperature were moni-
tored during surgery. The face mask and skin exposed to 
friction were lubricated with Vaseline. Electrocardiogram 
electrodes were kept in place with bandages, and Mepi-
tel (Mölnlycke Healthcare AB, Göteborg, Sweden) and soft 
gauze bandages were used to care for wounds and to se-
cure the IV line.
Postoperative pain control
For postoperative pain monitoring a visual-analogue scale 
(VAS) was used. Pain in infants was assessed in most cases 
by the mother using a VAS. In two cases, the infant CRIES 
scoring system (21) was combined with mother’s assess-
ment of the infant’s discomfort using the VAS.
To control pain during the early postoperative period, a 
multimodal approach was used. Non-steroidal anti-inflam-
matory drugs were administered with tramadol through 
continuous  IV  infusion.  Suppositories  were  not  used.  If 
needed, sedatives were also administered. Patients showed 
normal respiration and reported feeling no pain. For pre-
vention  of  postoperative  nausea  and  vomiting  (PONV), 
metoclopramide or dexamethasone was used.
statistical methods
Descriptive statistics, including median and range for the 
number  of  surgical  procedures,  were  used.  Frequencies 
of complications were presented as absolute values and 
percentages. For not normal distributions of variables, the 
Kruskal-Wallis test was used to test the significance of pre- 
and post-intervention outcomes.
Results
The sample consisted of 53 (31 male and 22 female) children 
with EB from 7 different countries who underwent a total of 
220 sessions of general anesthesia. Fifty-one of the 53 chil-
tABle 1. type of surgical procedures performed before and after introduction of procedural consolidation concept (PCC)
type of surgical procedure
total number o 
 procedures performed
Performed before PCC, 
No. (% of total)
Performed after PCC, 
No. (% of total)
Repair of syndactyly   39 14 (36)   25 (64)
Dilatation of esophageal strictures   42 11 (26)   31 (74)
Tooth repair   20   4 (20)   16 (80)
Tumor excision   10   1 (10)     9 (90)
Circumcision   11   2 (18)     9 (82)
PEG implantation*   4   1 (25)     3 (75)
Plastic reconstructive surgery 112 25 (22)   87 (78)
Body mapping 133 19 (14) 114 (86)
Formation of hand mold   23   9 (39)   14 (61)
Change of dressing 149 27 (18) 122 (82)
Wound tending 147 30 (20) 117 (80)
Biopsy of suspect skin changes   10   1 (10)     9 (90)
Contracture release   24   4 (17)   20 (83)
Ear/neck reconstructive surgery   16   2 (13)   14 (87)
Emergency   3   0 (0)     3 (100)
*PeG – percutaneous endoscopic gastrostomy.523 Karaman Ilić et al: Procedural consolidation concept and surgical treatment of children with epidermolysis bullosa
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dren underwent several sessions of anesthesia several times 
in a relatively short period. Eleven children (21%) had EB sim-
plex, 3 (6%) junctional EB, and 39 (73%) dystrophic EB.
The median age at the first surgery was 10 years (range 
1-19). Across all surgeries, the median age was 13 years 
(range 1-23). The median number of anesthesia adminis-
trations per patient was 3 (range 1-14).
Fifteen different surgical procedures were carried out 743 
times (Table 1). Between April 1999 and December 2004, 
150 surgical procedures were performed during 83 sessions 
of general anesthesia on a total of 39 patients. After the in-
troduction of PCC in January 2005, 593 surgical procedures 
were performed during 137 sessions of general anesthesia 
on 48 patients. The median number of procedures before 
PCC was introduced was 2 (range 1-5), compared with 4 
(range 3-7) afterwards (P < 0.001). Over the entire study pe-
riod, the median number of procedures carried out during 
a single session of anesthesia was 3 (range 1-7).
Development and frequency of 19 different complications 
were noted (Table 2). Complications occurred in all 53 pa-
tients. Over the entire period, the median number of com-
plications per session of anesthesia was 2 (range 0-10). The 
median number of complications per session of anesthesia 
increased after the introduction of PCC from 2 (range 0-10) 
to 3 (range 0-10) (P = 0.027). In contrast, the median num-
ber  of  complications  per  surgical  procedure  decreased 
from 1 (range 0-10) to 0.6 (range 0-2.5) after the introduc-
tion of PCC (P < 0.001) (Figure 1). The number of complica-
tions per patient was significantly lower before (median 2, 
range 1-20) than after (median 3, range 1-26) the introduc-
tion of PCC (P < 0.001).
PCC lengthened each anesthesia session from 65 minutes 
(range 35-655) to 95 minutes (range 50-405) (P < 0.001). 
The median number of surgical procedures per 10 min-
utes of anesthesia increased from 0.3 (range 0.0-0.6) to 0.4 
(range 0.1-0.9) (P < 0.001), without a change in the median 
number of complications per 10 minutes: 0.3 (range 0-1.3) 
vs 0.3 (range 0-0.9) (P = 0.56).
Over the entire study period, the median number of hospi-
talization days was 1 (range 1-4). The number of hospital-
ization days per session of anesthesia was not significantly 
tABle 2. Complications relative to the number of anesthesia sessions and surgical procedures before and after the introduction of 
procedural consolidation concept (PCC)*
overall Before PCC After PPC
Complication type
total 
number
% per 
No. 
anesthesia 
sessions 
(n = 220)
% per 
No. surgical 
procedures 
(n = 743)
total 
number
% per 
No. 
anesthesia 
sessions 
(n = 83)
% per 
No. 
surgical 
procedures 
(n = 150)
total 
number
% per 
No.  
anesthesia 
sessions 
(n = 137)
Drop in RBC count   63 29  8 21 25 14 42 30
New head and neck bullae   50 23  7 16 19 11 34 24
Oropharyngeal bullae   59 27  8 17 20 11 42 31
New skin injuries   14  6  2  7  8  5  7  5
PONV   58 26  8 23 28 15 35 26
Pain requiring treatment 104 47 14 31 37 21 73 53
Teeth damaged   12  5  2  4  5  3  8  6
Corneal erosions   4  2  1  1  1  1  3  2
SpO2≤90%   43 20  6 13 16  9 30 22
Multiple intubation attempts   20  9  3  7  8  5 13  9
Laryngospasm   6  3  1  1  1  1  5  4
Aspiration   3  1   0.4  0  0  0  3  2
Arrythmia   32 15  4 11 13  7 21 15
Hypotension   54 25  7 21 25 14 33 24
Delay awakening   6  3  1  2  2  1  4  3
Mechanical ventilation   3  1   0.4  1  1  1  2  1
Allergic reaction   3  1   0.4  1  1  1  2  1
Hypothermia   26 35  3  9 11  6 17 12
Swelling of IV line insertion   48 22  6 19 23 13 29 21
*Abbreviations: RBC – red blood cells; PoNV – post-operative nausea and vomiting; spo2 – pulse oxymeter oxygen saturation; IV – intravenous.CLINICAL SCIENCES 524 Croat Med J. 2011; 52: 520-6
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different before (median 1, range 1-4) and after (median 1, 
range 1-3) the introduction of PCC (P = 0.169). In contrast, 
the number of hospitalization days per surgical procedure 
was significantly higher before (median 1, range 0.75-1.75) 
than after (median 0.3, range 0.2-3) the introduction of PCC 
(P < 0.001) (Figure 2).
DIsCussIoN
This study was designed to investigate the impact of carry-
ing out multiple surgical procedures during a single session 
of general anesthesia in the treatment of children with EB. 
Our results show that after the introduction of PCC, anes-
thesia sessions became longer and the number of surgical 
procedures during one session increased. Although the ab-
solute number of complications increased, the rate of com-
plications per 10 minutes of anesthesia did not change. The 
overall length of hospital stay did not change, but the num-
ber of hospitalizations decreased significantly.
Although most surgical procedures on adult patients can 
be performed under local or regional anesthesia, other 
criteria apply to children with EB. The disease makes 
children more vulnerable and less tolerant, so even minor 
and trivial operations such as dressing changes, body map-
ping, and formation of hand molds are performed under 
general anesthesia.
During the study period, 15 different surgical procedures 
were performed and the occurrence of 19 complications 
was recorded. The frequency and number of complica-
tions in our study differ from previously published results 
(18-20,22). Iohom et al (1) reported their 20-year experi-
ence with anesthesia for children with EB. Fifty-six anesthe-
sia sessions (54 general and 2 local) were performed for 
58 procedures in 10 children. Two complications related 
to anesthesia occurred 10 times (PONV, 7; new bullae, 3). 
We observed a far higher rate of complications: complica-
tions arose in 209 of 220 anesthesia sessions, despite the 
application of preventive measures. This can be explained 
by the fact that development of typical complications for 
patients with EB (new head and neck bullae and/or new 
oropharyngeal  bullae)  were  reported  together  with  ad-
verse events associated with anesthesia (intubation, reac-
tion to medications used in the anesthesia, irregular heart-
beat, changes in blood pressure, pain and nausea, and 
Figure 1.
Distribution of the number of complications per procedure carried out 
during a single session of general anesthesia before and after the intro-
duction of procedural consolidation concept. small square – median, 
box – 25%-75% interval, whiskers – non-outlier range, circles – outliers, 
asterisk – extremes.
Figure 2.
 Distribution of days of hospitalization per procedure carried out during 
a single session of general anesthesia before and after introduction of 
procedural consolidation concept. small square – median, box – 25%-
75% interval, whiskers – non-outlier range, circles – outliers, asterisk – 
extremes.525 Karaman Ilić et al: Procedural consolidation concept and surgical treatment of children with epidermolysis bullosa
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vomiting) and with complications related to surgery (drop 
in red blood cells, hypothermia).
Patients with EB are most vulnerable during the intubation 
period and it is the time when most complications appear. 
Our study showed that after the introduction of PCC there 
was an increase in the number of surgical procedures in-
volving  the  oral  cavity  (dilatation  of  esophageal  stric-
tures, teeth repair) for which patients should be intubat-
ed (19,1,23). Surgeon and anesthesiologist share the same 
workspace which increases the chance of complications. 
This may explain the higher number of complications per 
anesthesia session after the introduction of PCC. Higher 
number of complications however did not influence dura-
tion of hospital stay.
Use of a laryngeal mask as an alternative to intubation was 
not considered for several reasons: it would reduce the al-
ready small workspace available for delicate procedures 
such as esophageal dilatation and tooth repair; most anes-
thesia sessions for syndactyly repair lasted longer than two 
hours, which is a contraindication for laryngeal mask; and 
the anesthesiologist on our team was well-trained in fiber 
optic intubation.
Although introduction of PCC led to a greater number of 
complications, this increase did not significantly prolong 
hospital stay. At the same time, PCC reduced the number 
of hospitalizations due to the smaller number of sessions of 
general anesthesia. The 593 surgical procedures that were 
carried out in the post-PCC group during 137 sessions of 
general anesthesia and 137 hospitalizations would have 
required, in the pre-PCC approach, 2.4-fold more hospital-
izations, with the associated risks and costs. A reduction 
in the number of hospitalizations, without any decrease in 
health services, translates into improved quality of life for 
children with EB, since it means less stress and distortion of 
established routines.
Although this study used a relatively large sample, there 
are some important limitations. The main ones are the ret-
rospective study design and insufficient data about the 
influence of patient age, co-morbidity, and the severity of 
complications. In addition, we examined only short-term 
perioperative  complications.  Patients  were  discharged 
from hospital when these complications were considered 
no longer life-threatening to patients. Although we did not 
perform longer-term follow-up, we were nevertheless able 
to show satisfactory results for standard EB findings, such 
as anemia and positive skin microbiological culture. Our 
patients were discharged with the recommendation that 
they continue outpatient supervision and treatment with 
a competent pediatrician and dermatologist. During the 
study period, discharged patients did not report any prob-
lems  related  to  recently  performed  surgical  procedures 
that would have required re-hospitalization.
Our results suggest that PCC is effective at reducing the 
exposure of patients with EB to the risks of general anes-
thesia. This approach requires the involvement of multidis-
ciplinary teams to plan, prepare, and coordinate treatment 
for each patient.
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